These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 16970149)
1. The role of vasopressin in congestive heart failure. Goldsmith SR Cleve Clin J Med; 2006 Sep; 73 Suppl 3():S19-23. PubMed ID: 16970149 [TBL] [Abstract][Full Text] [Related]
2. Hyponatremia in heart failure: the role of arginine vasopressin and its antagonism. Rosner MH; Ronco C Congest Heart Fail; 2010 Jul; 16 Suppl 1():S7-14. PubMed ID: 20653716 [TBL] [Abstract][Full Text] [Related]
3. [Neuro-hormonal mechanisms in heart insufficiency--from physiopathology to treatment]. Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; de Faria DB Rev Port Cardiol; 1989 Feb; 8(2):129-48. PubMed ID: 2576635 [TBL] [Abstract][Full Text] [Related]
4. Neurohormonal activation in congestive heart failure and the role of vasopressin. Chatterjee K Am J Cardiol; 2005 May; 95(9A):8B-13B. PubMed ID: 15847852 [TBL] [Abstract][Full Text] [Related]
5. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment]. Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306 [TBL] [Abstract][Full Text] [Related]
6. [Arginine vasopressin antagonism--new treatment option in chronic heart failure]. Solberg OG; Omland T Tidsskr Nor Laegeforen; 2007 Jan; 127(2):179-82. PubMed ID: 17237865 [TBL] [Abstract][Full Text] [Related]
12. Treatment options for hyponatremia in heart failure. Goldsmith SR Heart Fail Rev; 2009 Jun; 14(2):65-73. PubMed ID: 18777208 [TBL] [Abstract][Full Text] [Related]
13. Slowing the progression of CHF. Drug therapy to correct neurohormonal abnormalities. Ward RP; Anderson AS Postgrad Med; 2001 Mar; 109(3):36-8, 41-5. PubMed ID: 11265361 [TBL] [Abstract][Full Text] [Related]
14. Is too much neurohormonal blockade harmful? Anand IS Curr Cardiol Rep; 2004 May; 6(3):169-75. PubMed ID: 15075050 [TBL] [Abstract][Full Text] [Related]
15. Neurohormonal antagonism in heart failure; beneficial effects of vasopressin V(1a) and V(2) receptor blockade and ACE inhibition. Naitoh M; Risvanis J; Balding LC; Johnston CI; Burrell LM Cardiovasc Res; 2002 Apr; 54(1):51-7. PubMed ID: 12062361 [TBL] [Abstract][Full Text] [Related]
16. Congestive heart failure: potential role of arginine vasopressin antagonists in the therapy of heart failure. Goldsmith SR Congest Heart Fail; 2002; 8(5):251-6. PubMed ID: 12368587 [TBL] [Abstract][Full Text] [Related]
17. Plasma vasopressin as influenced by acute and chronic blockade of the renin-angiotensin system. Stanek B; Bruckner U; Silberbauer K J Hypertens Suppl; 1985 Nov; 3(2):S129-31. PubMed ID: 3003301 [TBL] [Abstract][Full Text] [Related]
18. The neurohumoral axis in congestive heart failure. Francis GS; Goldsmith SR; Levine TB; Olivari MT; Cohn JN Ann Intern Med; 1984 Sep; 101(3):370-7. PubMed ID: 6147109 [TBL] [Abstract][Full Text] [Related]